• First Round of Abstract Submission: March 05, 2026
  • Pre-Early Bird Ends: March 04, 2026
Millennium Hotel Paris Charles de Gaulle
2 Allée du Verger, 95700 Roissy-en-France

Speakers

Victoire de Margerie

Founder & CEO
Rondol Industrie
France

Sangwook Wu

CEO & CTO
PharmCADD
South Korea

Peter Timmerman

Head-Peptide Science
Biosynth B.V.
the Netherlands

Bruce Seligmann

CSO
BioSpyder Technologies, Inc.
Carlsbad, CA

Amin Li

VP-Medicinal Chemistry
Jacobio Pharma
China

Shiva Sharareh

Founder & CEO
Rekovar Inc
Irvine, CA

Mehdi Ashraf-Khorasani

Sr. Research Scientist
Virginia Tech
Blacksburg, VA

Chris Adams

CEO
Diopter Technologies
Somerville, MA

Shadi Hamoud

Deputy Director
Rambam Health Care Campus
Israel

Alan Wahl

President
DBiotherapeutics LLC
Seattle, WA

Joseph T Jr Nickels

Director
Institute of Metabolic Disorders
Trenton, NJ

William E. Roudebush

Clinical Professor
University of South Carolina
Greenville, SC

Karim Khaled

Assistant Professor
Lebanese American University
Lebanon

Cristina Scavone

Associate Professor
University of Campania “Luigi Vanvitelli”, Italy

Lin Wang

Co-Founder, CEO & President
Ascent Bio-Nano Technologies Inc., Morrisville, NC

Laszlo Fusti-Molnar

Founder
QuantumFuture Scientific Software LLC Buda, TX

Massimo Zollo

Professor
University of Naples Federico IIItaly

Despoina Pantazi

Chemist
University of Ioannina
Greece

Georg Voelcker

Research Associate
Goethe University Frankfurt Germany

Tony Jun Huang

William Bevan Distinguished Professor
Duke University Durham, NC